Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 37 - Drugs for immunological or allergic disorders
Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141)
08/2000
08/09/2000EP1025856A2 Methods for modulating T Cell unresponsiveness
08/09/2000EP1025855A1 Medicament comprising anti-CD3 and anti-Fcy-R antibodies for the treatment following organ transplantation
08/09/2000EP1025854A1 Use in immunotherapy of antibody anti CD3/TCR acting as depleting or as mitogenic agent
08/09/2000EP1025238A2 Death associated kinase containing ankyrin repeats (dakar)
08/09/2000EP1025124A1 Low-toxicity human interferon-alpha analogues
08/09/2000EP1025116A1 Estra-1,3,5(10)-triene-7alpha-thioethers
08/09/2000EP1025103A1 Novel polymorphic forms of cipamfylline
08/09/2000EP1025102A1 Bicyclic kinase inhibitors
08/09/2000EP1025082A1 Novel vitamin d derivatives with cyclopropyl rings in the lateral chains, a method and intermediate products for the production thereof and the utilization thereof for producing medicaments
08/09/2000EP1025079A1 $g(a)-ARYL-$i(N)-ALKYLNITRONES AND PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME
08/09/2000EP1024836A1 Method of delivering genes to antigen presenting cells of the skin
08/09/2000EP1024834A2 Hapten-carrier conjugates for use in drug-abuse therapy and methods for preparation of same
08/09/2000EP1024829A1 Tolerogenic fragments of natural allergens
08/09/2000EP1024827A1 Compositions and methods for systemic delivery of oral vaccines and therapeutic agents
08/09/2000EP1024825A1 Xenogeneic cholesteryl ester transfer protein (cetp) for modulation of cetp activity
08/09/2000EP1024822A1 Cd8 as an inhibitor of the cellular immune system
08/09/2000EP1024812A1 Compositions containing lysophosphatidic acids which inhibit apoptosis and uses thereof
08/09/2000EP1024809A1 Use of immunomodulating agents
08/09/2000EP1024701A1 Methods and compositions for the treatment of autoimmune disease using heat shock proteins
08/09/2000EP0690914B1 Allergenic protein and peptides from house dust mite and uses therefor
08/09/2000EP0642513B1 Indolocarbazole imides and their use
08/09/2000CN1262679A IL-5 inhibiting 6-azauracil derivatives
08/09/2000CN1262626A Antigen delivery system comprising monoglyceride or diglyceride derivatives as adjuvant
08/09/2000CN1262625A Use of lactoferin in treatment of allergen induced disorders
08/09/2000CN1262267A 20 kinds of modified vitamin D series derivatives, preparing and drug thereof
08/09/2000CN1262129A Pig erysipelothrix rhusiopathiae antigen and vaccine composition thereof
08/09/2000CN1055292C Anti-hyperplasia and anti-inflammatory pentose monosaccharide derivative and medicinal composition containing same
08/08/2000US6100409 Hydroxy and polyhydroxy derivatives of coumarin, preparation thereof and antiviral action thereof
08/08/2000US6100387 Chimeric polypeptides containing chemokine domains
08/08/2000US6100377 Aromatically adjusted and confined amino acid sequences; for the development of more efficient synthetic polypeptides
08/08/2000US6100290 Photodynamic therapy in selective cell inactivation in blood and treating immune dysfunction diseases
08/08/2000US6100284 Antiallergens
08/08/2000US6100271 Compounds which mediate intracellular signaling response to abnormal external stimuli characteristic of diseases; antiinflammatory agents, antifibrotic agents, antisclerotic agents, antitumor agents
08/08/2000US6100266 Hydroxamic and carboxylic acid derivatives
08/08/2000US6100259 Cannabinoid receptor modulators
08/08/2000US6100235 Methods of treating immune and inflammatory response with IL-17 receptors
08/08/2000US6100234 Treatment of HIV
08/08/2000US6100088 Viral vaccines
08/08/2000US6100037 Polynucleotide encoding a cyclic nucleotide phosphodiesterase having a specific amino acid sequence; diagnosis, treatment, and prevention of cancer and immune disorders; anticarcinogenic/antidiabetic/antiarthritic agents
08/08/2000US6099848 Immunogenic compositions comprising DAL/DAT double-mutant, auxotrophic, attenuated strains of Listeria and their methods of use
08/08/2000US6099838 For the prevention or reversal of transplant rejection as well as therapy for autoimmune diseases
08/08/2000CA2185019C Isoxazoline compounds as inhibitors of tnf release
08/08/2000CA2071907C Bcrf1 proteins as inhibitors of interferon-y
08/03/2000WO2000044904A1 Basb059 polypeptides from neisseria meningitidis
08/03/2000WO2000044900A2 Nucleic-acid binding proteins
08/03/2000WO2000044899A1 Her-2/neu fusion proteins
08/03/2000WO2000044887A1 Peptides and proteins for desensitizing subjects allergic to bee venom and compositions containing same
08/03/2000WO2000044884A1 Bhv-1 gene-deleted virus vaccine
08/03/2000WO2000044862A1 Process of converting rendered triglyceride oil from marine sources into bland, stable oil
08/03/2000WO2000044790A1 Anti-ccr1 antibodies and methods of use therefor
08/03/2000WO2000044788A1 Production of tetravalent antibodies
08/03/2000WO2000044781A1 Alleviation of the allergenic potential of airborne and contact allergens by thioredoxin
08/03/2000WO2000044763A2 Compositions for treating inflammatory response
08/03/2000WO2000044758A1 Immunological adjuvant compound
08/03/2000WO2000044756A1 Thiazolopyrimidine compounds, process for the preparation of the same and uses thereof
08/03/2000WO2000044749A1 Acetylenic ortho-sulfonamido and phosphinic acid amido bicyclic heteroaryl hydroxamic acids as tace inhibitors
08/03/2000WO2000044740A2 Heteroaryl acetylenic sulfonamide and phosphinic acid amide hydroxamic acid tace inhibitors
08/03/2000WO2000044733A1 Peptidyl heterocyclic ketones useful as tryptase inhibitors
08/03/2000WO2000044730A1 2,3,4,5-tetrahydro-1h-[1,4]benzodiazepine-3-hydroxamic acid as matrix metalloproteinase inhibitors
08/03/2000WO2000044716A1 Acetylenic sulfonamide thiol tace inhibitors
08/03/2000WO2000044713A1 Alkynyl containing hydroxamic acid compounds as tace inhibitors
08/03/2000WO2000044711A1 ACETYLENIC $G(b)-SULFONAMIDO AND PHOSPHINIC ACID AMIDE HYDROXAMIC ACID TACE INHIBITORS
08/03/2000WO2000044710A2 Acetylenic aryl sulfonamide and phosphinic acid amide hydroxamic acid tace inhibitors
08/03/2000WO2000044709A2 ACETYLENIC α-AMINO ACID-BASED SULFONAMIDE HYDROXAMIC ACID TACE INHIBITORS
08/03/2000WO2000044408A2 Method of treating demyelinating inflammatory disease using ccr1 antagonists
08/03/2000WO2000044402A1 Pharmaceutical composition comprising a selected antigen and candida species antigen and methods
08/03/2000WO2000044388A1 Modulation of immune response by ribavirin
08/03/2000WO2000044375A1 Antioxidant compositions and methods for companion animals
08/03/2000WO2000044365A1 Methods for preventing graft rejection and ischemia-reperfusion injury
08/03/2000WO2000044350A1 Transnasal transport/immunisation with highly adaptable carriers
08/03/2000WO2000044349A1 Non-invasive vaccination through the skin
08/03/2000WO2000028947A3 Use of a substance binding with the peripheral benzodiazepin receptor for treating skin stress
08/03/2000WO2000027999A3 Lymphoid tissue-specific cell production from hematopoietic progenitor cells in three-dimensional devices
08/03/2000WO2000027881A3 Human interleukin 10 mutant proteins
08/03/2000WO2000027850A3 Crf receptor antagonists and methods relating thereto
08/03/2000WO2000023105A3 Adjuvant systems and vaccines
08/03/2000WO2000009102A9 Carboxylic acids and isosteres of n-heterocyclic compounds for vision and memory disorders
08/03/2000WO2000006589A9 Prostate derived ets factor
08/03/2000WO2000006146A9 Substituted anilide compounds and methods
08/03/2000WO1999063975A3 A method for stimulating the immune system
08/03/2000WO1999026942A8 5-(2-imidazolinylamino)-benzimidazole derivatives, their preparation and their use as .alpha.-adrenoceptor agonists with improved metabolic stability
08/03/2000CA2368214A1 Alleviation of the allergenic potential of airborne and contact allergens by thioredoxin
08/03/2000CA2363565A1 Basb059 polypeptides from neisseria meningitidis
08/03/2000CA2361614E Compositions for treating inflammatory response
08/03/2000CA2361479A1 Peptidyl heterocyclic ketones useful as tryptase inhibitors
08/03/2000CA2361256A1 Method of treating demyelinating inflammatory disease using ccr1 antagonists
08/03/2000CA2360672A1 Methods for preventing graft rejection and ischemia-reperfusion injury
08/03/2000CA2360643A1 Transnasal transport/immunisation with highly adaptable carriers
08/03/2000CA2360082A1 Peptides and proteins for desensitizing subjects allergic to bee venom and compositions containing same
08/03/2000CA2360019A1 Anti-ccr1 antibodies and methods of use therefor
08/03/2000CA2359994A1 Production of tetravalent antibodies
08/03/2000CA2359701A1 Nucleic-acid binding proteins
08/03/2000CA2359011A1 Thiazolopyrimidine compound, its production and use
08/03/2000CA2357735A1 Modulation of immune response by ribavirin
08/03/2000CA2356855A1 Acetylenic aryl sulfonamide and phosphinic acid amide hydroxamic acid tace inhibitors
08/03/2000CA2356481A1 Heteroaryl acetylenic sulfonamide and phosphinic acid amide hydroxamic acid tace inhibitors
08/03/2000CA2356480A1 Acetylenic sulfonamide thiol tace inhibitors
08/03/2000CA2356346A1 Alkynyl containing hydroxamic acid compounds as tace inhibitors
08/03/2000CA2356345A1 Acetylenic beta-sulfonamido and phosphinic acid amide hydroxamic acid tace inhibitors
08/03/2000CA2356313A1 Alkynyl containing hydroxamic acid derivatives, their preparation and their use as matrix metalloproteinase (mmp) inhibitors/tnf-alpha converting enzyme (tace) inhibitors
1 ... 927 928 929 930 931 932 933 934 935 936 937 938 939 940 941 942 943 944 945 946 947 ... 1172